je.st
news
Tag: drugs
FDA warns of deadly liver damage with AbbVie hepatitis drugs
2015-10-25 14:37:13| Biotech - Topix.net
Federal health officials are warning doctors and patients that two hepatitis C drugs from AbbVie can cause life-threatening liver injury in patients with advanced forms of the disease. The Food and Drug Administration said Thursday it will require AbbVie to add new warnings to Viekira Pak and Technivie after reported deaths and liver transplants in patients who already had liver damage caused by hepatitis C. The warning could reshape the growing field of high-priced drugs to treat the virus, which also includes Gilead Sciences' blockbuster medications Sovaldi and Harvoni.
Tags: damage
drugs
liver
deadly
FDA adds liver warning to AbbVie hepatitis C drugs
2015-10-23 01:36:32| Biotech - Topix.net
Federal health officials are warning doctors and patients that two hepatitis C drugs from AbbVie can cause life-threatening liver injury in patients with advanced forms of the disease. The Food and Drug Administration said Thursday it will require AbbVie to add new warnings to Viekira Pak and Technivie about their risks for patients who already have advanced liver damage caused by hepatitis C. The warning could reshape the growing field of high-priced drugs to treat the virus, which also includes Gilead Sciences' blockbuster medications Sovaldi and Harvoni.
Tags: warning
drugs
adds
liver
Roche sees strong growth from breast cancer drugs
2015-10-22 13:02:38| Biotech - Topix.net
Roche Holding AG expects strong growth from its recent breast cancer drugs Perjeta and Kadcyla well into 2017, the company's head of pharmaceuticals said. Perjeta and Kadcyla increased sales by 66% and 57% respectively in the first nine months of 2015, Roche said Thursday as the Basel company announced a 2% increase in sales during the period.
Tags: strong
growth
cancer
drugs
Insight - US cancer doctors drop pricey drugs with little or no effect
2015-10-08 13:59:06| Biotech - Topix.net
U.S. oncologists, aware that patients are paying more of the costs of expensive cancer drugs, are increasingly declining to prescribe medicines that have scant or no effect, even as a last resort. A cancer patient pushes his drip stand as he walks down the hallway of the Beijing Cancer Hospital July 12, 2011.
U.S. cancer doctors drop pricey drugs with little or no effect
2015-10-08 09:35:52| Chemicals - Topix.net
U.S. oncologists, aware that patients are paying more of the costs of expensive cancer drugs, are increasingly declining to prescribe medicines that have scant or no effect, even as a last resort. At least half a dozen drugs, including colon cancer treatments Cyramza, from Eli Lilly & Co, and Stivarga, sold by Bayer AG, aren't worth prices that can exceed $100,000 a year, top cancer specialists said in interviews with Reuters.
Tags: effect
drop
cancer
drugs
Sites : [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] next »